Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

Improvements in screening and adjuvant therapy for breast cancer are associated with decreased recurrence, which may have the effect of increasing the proportion of patients presenting with first-line de novo versus recurrent metastatic breast cancer (MBC). Here, we describe and compare patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yardley, Denise A., Kaufman, Peter A., Brufsky, Adam, Yood, Marianne Ulcickas, Rugo, Hope, Mayer, Musa, Quah, Cheng, Yoo, Bongin, Tripathy, Debu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031392/
https://www.ncbi.nlm.nih.gov/pubmed/24706168
http://dx.doi.org/10.1007/s10549-014-2916-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031392/
https://www.ncbi.nlm.nih.gov/pubmed/24706168
http://dx.doi.org/10.1007/s10549-014-2916-8

Ejemplares similares